clec-69

Caenorhabditis elegans

Is affected by several genes including dys-1; hyl-1; and sta-1 based on RNA-seq and microarray studies. Is affected by twenty chemicals including rotenone; D-glucose; and sesamin based on RNA-seq and microarray studies.

dyb-1

Caenorhabditis elegans

Enables acetylcholine transmembrane transporter activity and cytoskeletal protein binding activity. Involved in several processes, including muscle cell cellular homeostasis; positive regulation of cholinergic synaptic transmission; and sarcomere organization. Located in plasma membrane. Part of dystrobrevin complex. Expressed in body wall musculature; non-striated muscle; somatic nervous system; and tail neurons. Used to study Duchenne muscular dystrophy. Human ortholog(s) of this gene implicated in left ventricular noncompaction. Is an ortholog of human DTNA (dystrobrevin alpha).

W06H8.5

Caenorhabditis elegans

Enriched in head mesodermal cell; intestine; and neurons based on RNA-seq and microarray studies. Is affected by several genes including cyc-1; dys-1; and nuo-6 based on microarray; tiling array; and RNA-seq studies. Is affected by eight chemicals including silicon dioxide nanoparticle; Oligosaccharides; and paraquat based on microarray and RNA-seq studies.

Y62H9A.3

Caenorhabditis elegans

Enriched in RIM; interneuron; and spermatheca based on RNA-seq and single-cell RNA-seq studies. Is affected by several genes including cyc-1; dys-1; and swsn-2.2 based on microarray; tiling array; proteomic; and RNA-seq studies. Is affected by twenty chemicals including Ethanol; 1-methylnicotinamide; and rotenone based on RNA-seq; microarray; and proteomic studies.

F15E6.4

Caenorhabditis elegans

Enriched in ASER; PLM; anchor cell; hyp12; and hypodermis based on tiling array; RNA-seq; and single-cell RNA-seq studies. Is affected by several genes including dys-1; hyl-1; and swsn-2.2 based on microarray and RNA-seq studies. Is affected by twenty-seven chemicals including methylmercuric chloride; rotenone; and Tunicamycin based on microarray and RNA-seq studies.

Y17D7B.4

Caenorhabditis elegans

Enriched in head mesodermal cell; head muscle; intestine; muscle cell; and neurons based on tiling array; RNA-seq; single-cell RNA-seq; and microarray studies. Is affected by several genes including dys-1; cyd-1; and mut-2 based on RNA-seq and microarray studies. Is affected by thirteen chemicals including rotenone; stavudine; and Psoralens based on RNA-seq and microarray studies.

Y17D7B.7

Caenorhabditis elegans

Enriched in cholinergic neurons; head mesodermal cell; mechanosensory neurons; and muscle cell based on RNA-seq; single-cell RNA-seq; and microarray studies. Is affected by several genes including cyc-1; dys-1; and mut-16 based on microarray and RNA-seq studies. Is affected by twelve chemicals including methylmercury hydroxide; Psoralens; and allantoin based on RNA-seq and microarray studies.

F15E6.3

Caenorhabditis elegans

Enriched in anterior hypodermis; hyp12; hyp2; hypodermis; and intestine based on single-cell RNA-seq and microarray studies. Is affected by several genes including fzo-1; cyc-1; and dys-1 based on microarray and RNA-seq studies. Is affected by thirty chemicals including 1-methylnicotinamide; methylmercuric chloride; and rotenone based on RNA-seq and microarray studies.

ZC373.2

Caenorhabditis elegans

Enriched in AVK; dopaminergic neurons; excretory gland cell; germ line; and hermaphrodite gonad based on tiling array; RNA-seq; and single-cell RNA-seq studies. Is affected by several genes including cyc-1; dys-1; and swsn-2.2 based on microarray; RNA-seq; and proteomic studies. Is affected by thirteen chemicals including Heme; Ethanol; and rotenone based on microarray and RNA-seq studies.

Y81G3A.4

Caenorhabditis elegans

Enriched in PLM; Z1; Z4; hypodermis; and somatic gonad precursor based on tiling array; RNA-seq; and single-cell RNA-seq studies. Is affected by several genes including cyc-1; dys-1; and swsn-1 based on microarray and RNA-seq studies. Is affected by fifteen chemicals including methylmercury hydroxide; rifampin; and allantoin based on RNA-seq and microarray studies.